The GSK Medicines Research Unit is a dedicated clinical pharmacology unit situated within the Prince of Wales Hospital, in Sydney, Australia. The location provides access to a comprehensive range of medical services and research facilities within in a large teaching hospital as well as the adjacent University of New South Wales.

Our goal is to contribute to GSK’s mission to improve the quality of human life by enabling people to do more, feel better and live longer by efficiently delivering early phase clinical trial services to the highest quality standard.

Quality is at the heart of everything we do – from planning through to clinical trial management, clinical vigilance and laboratory procedures – and is vital to the delivery of reliable science for drug development.

All clinical trials are conducted to ethical standards as defined by ICH (E6) GCP, the National Statement on Ethical Conduct in Research Involving Humans (issued by the National Health and Medical Research Council in Australia), and other applicable regulatory and GSK requirements. This includes the safety and well being of study participants, their rights, confidentiality of their data and personal information.

The Unit is funded by GSK Australia with a self-financing business model. Since the first study, in June 1999, approximately 70 studies have been performed at the Unit predominantly on behalf of GSK and also for external pharmaceutical and biotech companies.

Dr Franziska Loehrer, General Manager

Please use these links for navigation through the GSK Medicines Research Unit pages:

Overview of Research Unit
Services & Clinical Operations
Our Facilities
Meet the Team
Contact Us
Volunteer & Registration Information
Current Clinical Trials